The surgical table market is expected to grow massively by 2028 owing to increasing need for surgical procedures across the globe. In addition, changing lifestyles, growing population, and the burgeoning healthcare burden are slated to further drive market growth through the forecast timeframe.

During the coronavirus pandemic, elective surgeries were postponed in order to prevent people from getting infected in hospital settings, which hampered the demand for surgical tables. However, recent ease in lockdown restrictions and an increasing number of heart-related diseases have encouraged innovations in the sector, thereby fostering advancements in the surgical table market.

Moreover, major players in the surgical table space have been focusing on business strategies like commercialization and expansion of their product lines. For instance, in October 2021, Stille AB, a leading medical instruments manufacturer, introduced its new general surgery table GS2, developed in collaboration with global medical technology expert GE Healthcare. The launch provided a cost-effective high-value solution while accommodating the need for multi-disciplinary surgery units.

The surgical table market has been bifurcated in terms of material, end-use, surgery type, product type, the region. In terms of surgery type, the market has been further divided into specialty surgical tables, radiolucent surgical tables, general surgical tables, and pediatric surgical tables. The general surgical tables segment was valued at more than USD 597 million in 2021 and is projected to grow at a CAGR of over 3.5% through the analysis timeframe due to escalating demand for general surgeries across the world.

By product type, the surgical table market has been split into powered and non-powered. In 2021, the powered segment was exceeded a valuation of USD 1,124 million and is speculated to depict approximately 3.9% CAGR over the study timeline on account of increasing prevalence of end-stage chronic diseases and rising global geriatric population.

With reference to material, the market has been categorized into metal and composite. The metal segment held a considerable market share in 2021 and is estimated to reach above USD 1,315 million by 2028. Lower cost of metal tables as compared to composite surgical tables, coupled with high adoption rate and demand, is likely to drive segmental growth.

In the context of end-use, the surgical table industry has been segregated into ambulatory surgery centers, hospitals and clinics, and others. In 2021, the hospitals and clinics segment was valued at more than USD 871 million and is projected to grow at a CAGR of nearly 3.6% by 2028 due to surging patient preference for hospitals driven by surging adoption of advanced surgical tables and better healthcare facilities available at hospitals.

In the regional landscape, the North America surgical table market surpassed USD 478 million in revenue in 2021 and is forecast to grow at around 3.1% CAGR through 2028. Technological advancements in surgical tables and government initiatives taken to promote the market in the region